جست‌وجوی استاد و پژوهشگر

• Pharmaceutical Technology
• Drug Delivery Systems
• Nanoparticle Formulation
• +۳ مورد دیگر

Maria del Rosario Aberturas Ramos is a Professor in the Department of Biomedical Sciences at the University of Alcalá's School of Pharmacy. With an academic career spanning from 1984 to 2023, she has established herself as a specialist in pharmaceutical technology and drug delivery systems. Her institutional profile shows consistent scholarly activity through publications, thesis supervision, and editorial contributions to academic proceedings. Her research interests focus on pharmaceutical formulation , particularly in the development of nanoparticle delivery systems for various therapeutic applications. She has made significant contributions to the understanding of PLGA and chitosan-based nanoparticles , drug encapsulation techniques , and the formulation of topical products including sunscreens. Her work bridges fundamental pharmaceutical science with practical therapeutic applications. Analysis of her publication record reveals a strong trajectory in advanced drug delivery systems , with recent work emphasizing natural product delivery (particularly turmeric) and cancer therapeutics . Her research demonstrates consistent evolution from foundational work in topical formulations to sophisticated nanoparticle-based delivery systems. As an academic advisor, she has directed two doctoral theses, most recently co-directing Ana Luísa Gomes Júlio's 2023 work on ionic liquids for sustained delivery systems. Her collaborative network includes prominent researchers such as Jesús Molpeceres García del Pozo, with whom she has co-authored multiple publications across decades. Professionally, she has served as a literary editor for the XVI SEFIG Congress proceedings in 2023, demonstrating her standing within the Spanish Society of Industrial and Galenic Pharmacy. Her academic contributions extend to textbook authorship, including the 2022 'Dermopharmacy and Health Products Practice Notebook' published by the University of Alcalá Press.

• Bible studies
• Ancient Near Eastern studies
• Biblical archaeology
• +۴ مورد دیگر

Shalom E. Holtz is Professor of Bible at Yeshiva University, specializing in the intersection of biblical texts with ancient Near Eastern legal and religious practices. His academic career focuses on contextualizing biblical law and literature within the broader cultural and historical framework of the ancient Near East. Dr. Holtz's research expertise includes: Neo-Babylonian legal procedures and their relationship to biblical law Ancient Near Eastern treaty formulations reflected in biblical covenants Temple worship practices and their evolution in ancient Israel Comparative study of biblical and Mesopotamian religious texts Cuneiform documentation of legal proceedings relevant to biblical interpretation His scholarly publications demonstrate a consistent methodological approach that combines textual analysis of biblical passages with archaeological evidence and ancient Near Eastern documentation, particularly cuneiform records. This interdisciplinary methodology has yielded significant insights into the historical context of biblical narratives, legal formulations, and religious practices. Dr. Holtz has established scholarly recognition through publications with prestigious academic presses including Brill (Cuneiform Monographs series), the Society of Biblical Literature, and Brown Judaic Studies. His academic leadership is evident through his extensive publication record and contributions to biblical scholarship, though specific details about direct student mentoring are not prominently documented in available sources. His work represents an important bridge between biblical studies and ancient Near Eastern scholarship.

Gavin Halbertمشاهده پروفایل

استاد مهمان

• Pharmaceutical Formulation
• Drug Targeting and Delivery Systems
• Medicinal Chemistry
• +۶ مورد دیگر

Gavin Halbert serves as Visiting Professor at the Strathclyde Institute of Pharmacy and Biomedical Sciences (SIPBS), University of Strathclyde, where he directs the Formulation Unit responsible for pharmaceutical development of novel anti-cancer agents for clinical trials. With over 40 years at SIPBS since joining as lecturer in 1984, he has pharmaceutical oversight for more than 20 new chemical entities in human trials. His educational background includes: Pharmacy degree (1979), University of Strathclyde PhD in Physiochemical Aspects of Anti-Cancer Drug Targeting Systems (1984), University of Strathclyde Research focuses on advanced pharmaceutical formulation, drug targeting systems for cancer chemotherapy (including synthetic Low Density Lipoprotein platforms), GMP production for Phase I trials, and lyophilisation technology. His fingerprint analysis reveals expertise in drug delivery, tablet formulation, polymer science, and dissolution kinetics within pharmacological sciences. Recent publications demonstrate emerging trends in digital design for sustainable medicines development and biophysical characterisation of novel antibody therapeutics, reflecting convergence of pharmaceutical engineering with cancer immunotherapy. Scientific recognition includes: Fellow of Royal Society of Chemistry (2024) Fellow of Royal Pharmaceutical Society (FRPS) (2024) With over £10 million in career grant funding, he leads major initiatives including the DHSC Future Manufacturing Vaccine Hub (2023-2028) and Cancer Research UK Formulation Unit (2020-2025). He supervises postgraduate students and teaches the Qualified Persons training course since 1991. The Formulation Unit under his directorship since 1992 operates specialized GMP facilities for manufacturing clinical trial materials, supported by equipment including Agilent HPLC systems and collaborative networks with CRUK and pharmaceutical industry partners.

Feng Zhangمشاهده پروفایل

دانشیار

• Drug Delivery
• Pharmaceutical Formulation
• Polymer Science
• +۵ مورد دیگر

Feng Zhang, Ph.D. serves as an Associate Professor of Molecular Pharmaceutics and Drug Delivery in the College of Pharmacy at the University of Texas at Austin. He joined the university in January 2014 as an Assistant Professor and was promoted to Associate Professor with tenure in September 2020. His research program focuses on advanced pharmaceutical technologies for drug delivery and manufacturing. Dr. Zhang earned his B.S. in Pharmaceutical Science from China Pharmaceutical University in 1994 and completed his Ph.D. in Pharmaceutical Science at the University of Texas at Austin in 1999. Prior to his academic appointment, he gained extensive industry experience working as a Research Scientist at PharmaForm (2000-2010) and Gilead Sciences (2011-2013). His laboratory investigates three primary research areas: (1) formulation, processing, and characterization of melt-extruded long-acting implants, (2) investigation of process-induced transformation of API during twin-screw continuous granulation, and (3) simulation and modeling of melt extrusion for preparing amorphous solid dispersions to enhance bioavailability of poorly soluble drugs. His work addresses critical challenges in pharmaceutical manufacturing, particularly the development of continuous processing methods and bioavailability enhancement technologies for BCS Class 2 and 4 drugs. Dr. Zhang's publication record demonstrates consistent productivity in high-impact pharmaceutical journals, with research focusing on advanced drug delivery systems, continuous manufacturing technologies, and bioavailability enhancement strategies. His work shows a strong trend toward implementing continuous manufacturing processes in pharmaceutical production and developing novel analytical methods to characterize complex drug delivery systems. Dr. Zhang has secured research funding from multiple sources including PhRMA Foundation, Food and Drug Administration, Foster Delivery Sciences, Ashland Chemical, and American Leistritz Extruder Corporation. His laboratory has produced numerous publications and trained many successful pharmaceutical scientists. Dr. Zhang currently mentors several graduate students and postdoctoral fellows in the Zhang Lab, focusing on biodurable implants, continuous twin-screw melt granulation, and biodegradable implant research. His former students have secured positions at major pharmaceutical companies including AbbVie, Merck & Co., Sanofi, and Gilead Sciences.

Jihong Hanمشاهده پروفایل

مدرس

• Pharmaceutics
• Drug Delivery Systems
• Nanoparticle Formulation
• +۳ مورد دیگر

Dr. Jihong Han is a Lecturer in Pharmaceutics at the School of Allied Health Professions and Pharmacy, Keele University. Previously, she worked at the Nottingham School of Pharmacy and London School of Pharmacy. Her research focuses on particulate drug delivery systems, particularly the formulation and evaluation of nanosuspensions and emulsions. Specific interests include surface modification of particles using polymers and optimizing drug delivery processes to enhance bioavailability and stability. She currently serves as Examinations Officer and contributes to the Keele Centre for Medicines Optimisation (KCMO). Her work spans over three decades, with publications on topics such as paclitaxel emulsion design, tacrolimus pediatric suspensions, and nanotechnology-based drug delivery. Dr. Han's research emphasizes translational applications in oncology, antifungal therapy, and pediatric drug formulations. Her publications consistently address challenges in pharmaceutical formulation, including particle size control, chemical stability, and in vivo targeting. Collaborative projects with teams in China and the UK highlight her global impact in drug delivery science. While no formal awards are listed, her extensive publication record reflects sustained contributions to the field. Teaching and administrative roles complement her research, ensuring alignment with academic and professional training in pharmacy practice.

• Pharmaceutical Technology
• Industrial Pharmacy
• Dosage Form Design
• +۷ مورد دیگر

Professor Dimitrios M. Rekkas is a distinguished academic and researcher in Pharmaceutical Technology, affiliated with the School of Pharmacy at the University of Athens. He holds the position of Professor of Pharmaceutical Technology and serves as Director of the Pharmaceutical Technology Laboratory and the Pharmaceutical Technology Division. His roles include leadership in academic and professional organizations, such as Vice President of the Management Committee of European Program COST 865-Bioencapsulation and Dean of the Department of Pharmacy at NKUA. He has also held visiting professorships at renowned institutions like the University of Vienna and University of Parma, Italy. Prof. Rekkas' education includes a B.Pharm. and PhD in Pharmaceutical Technology from the University of Athens, and an MSc in Total Quality Management from Sheffield Hallam University, UK. His research focuses on Pharmaceutical Technology, Industrial Pharmacy, Dosage Form Design, and Quality by Design (QbD), with a strong emphasis on experimental design, statistical process control, and quality assurance. He has contributed significantly to the development of dry powder inhalers, nasal drug delivery systems, and innovative manufacturing processes using 3D printing and other advanced techniques. Prof. Rekkas has coordinated international projects, including the PHAR-QA initiative for European pharmacy education quality assurance and the SimInhale Cost Action on inhaled medicines. He has authored a textbook on Total Quality Management and holds multiple patents related to pharmaceutical formulations and processes. His work bridges academic research with industrial applications, emphasizing practical solutions for drug delivery and manufacturing excellence.

Anne Schweighardtمشاهده پروفایل

دانشیار

• Internal Medicine
• Medication Safety
• Solid Dispersion Technologies
• +۳ مورد دیگر

Anne Schweighardt is Associate Professor and Chair of Pharmacy Practice and Administration at St. John Fisher University's Wegmans School of Pharmacy. Her research focuses on medication safety, particularly crushability analysis of solid dosage forms. Education: Pharm.D., University of Utah Pharmacotherapy Residency, Texas Tech University Clinical practice centers on internal medicine at Strong Memorial Hospital. Recent publications analyze pharmaceutical formulations from FDA novel drug approvals to expand the ISMP Do Not Crush List. Research addresses hepatic dosing adjustments and automated medication dispensers for adherence improvement. Awards: Three-time recipient Wegmans School of Pharmacy Faculty Preceptor of the Year

Kevin Croninمشاهده پروفایل

مدرس ارشد

• Process Engineering
• Probabilistic Simulation
• Thermal Processing
• +۷ مورد دیگر

Dr. Kevin Cronin is a Senior Lecturer in Process Engineering at the Department of Process & Chemical Engineering, University College Cork (UCC). His academic career includes roles at the University of Ulster and the SKF Engineering and Research Centre. He holds a BE (Mech) from University College Dublin, a MEngSc in Tribology from UCD, and a PhD in Mechanical Engineering from Brunel University (UK). His research focuses on probabilistic simulation of thermal processing in food engineering, mechanical design of process equipment, and process safety. Key areas include variability analysis in food processing, vessel structural integrity, and timber drying optimization. Research interests span computer modelling techniques like Monte Carlo methods and Markov chains, with applications in food quality, process safety, and material behavior. Notable projects include probabilistic studies on food processing variability, vessel collapse analysis, and bioprocessing equipment design. His work integrates stochastic analysis to enhance industrial processes, such as optimizing energy consumption in timber drying and mitigating risks in pharmaceutical solvent transfer systems. Publications highlight contributions to food engineering, material science, and mechanical systems. Recent articles address rehydration behaviors of dairy powders, particle dynamics in vibrating systems, and compliant gripper design. Teaching responsibilities include modules on process safety, mechanical design, and engineering materials.

Faisal Abbasمشاهده پروفایل

پژوهشگر ارشد

• Robotics
• Automation
• Control Systems
• +۳ مورد دیگر

Faisal Abbas is a Research Fellow at the Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde. His work focuses on Robotics, Automation, Control, and Instrumentation, with current research on automated microscale medicine manufacturing systems under the Made Smarter Innovation project. He holds a PhD in Electronic Engineering from the University of Kent (2022), where he specialized in data-driven modeling of mass flow in pneumatic systems. Abbas has prior experience as an Associate Lecturer in Electrical Engineering at the National University of Computer and Emerging Sciences (NUCES). Education: Bachelor's in Electrical Engineering (2014) - NUCES Master's in Electrical Engineering (2017) - NUCES PhD in Electronic Engineering (2022) - University of Kent Research Interests: Robotics and automation in pharmaceutical manufacturing, control systems, data-driven modeling, and sustainable drug production aligned with UN SDGs. His expertise bridges engineering and biomedical sciences, addressing challenges in dosage form validation and particle dynamics. Notable Projects: Leading the development of an automated microscale medicine manufacturing system (DM² project) Co-investigator on the Industrial CASE Account project (EPSRC-funded) Awards: Recipient of the Vice Chancellor’s Award (2018) from the University of Kent for academic excellence. Collaborations: Involved in multidisciplinary teams including the Centre for Continuous Manufacturing and Advanced Crystallization. Presented research at conferences like the 2022 Invited Talk on Sensor Enabled Automation.

Jason Locklinمشاهده پروفایل

استاد

• Materials Science
• Polymer Chemistry
• Biomedical Engineering
• +۳ مورد دیگر

Jason Locklin is a Professor at the University of Georgia (UGA), leading the New Materials Institute and contributing to UGA’s partnership with Advanced Functional Fabrics of America (AFFOA). His research focuses on biodegradable polymers, antimicrobial surfaces, and sustainable materials engineering. He holds the NSF CAREER Award (2010) and CIA Young Investigator Award (2007). Education: Ph.D. in Materials Science. Professional roles include founding director of the New Materials Institute and key collaborator in AFFOA, a DOD-funded initiative advancing textile and fiber innovations. Research interests span biodegradable plastics, nanocomposites, and medical device coatings. Notable projects include developing antifouling surfaces, compostable adhesives, and materials for healthcare and environmental sustainability. Awards: NSF CAREER Award (2010), CIA Young Investigator Award (2007). Grants: NSF and DOD funding. Advising: Mentors students in multidisciplinary research. Lab: New Materials Institute focuses on circular economy solutions.

• Drug Delivery Systems
• Pharmaceutical Nanotechnology
• Biopharmaceutics
• +۳ مورد دیگر

Maureen D. Donovan is a Professor of Pharmaceutical Sciences and Experimental Therapeutics at the University of Iowa's College of Pharmacy. Her primary office is located in the Iowa Bioscience Innovation Facility (IBIF) at 115 S. Grand Ave, Iowa City. Her research focuses on advanced drug delivery systems, particularly in nasal and gastrointestinal drug delivery, nanoparticle design for targeted therapies, and abuse-deterrent formulations. Her work integrates biopharmaceutics principles with nanotechnology to improve drug absorption efficiency and safety. Recent publications (2020-2024) emphasize nasal mucosal uptake mechanisms, membrane transporter interactions, and formulation optimization for pH-sensitive drugs. Her studies often combine in vitro models with advanced analytical techniques like electron spin resonance. Donovan maintains active collaborations across disciplines, evidenced by multi-author publications involving toxicology, material science, and clinical pharmacy.

• Pharmaceutical powder flow prediction
• Deep learning applications in pharmaceuticals
• Tablet dissolution performance modeling
• +۳ مورد دیگر

Dr. John Armstrong is a Research Fellow at the Strathclyde Institute of Pharmacy and Biomedical Sciences within the University of Strathclyde's Faculty of Science. His work focuses on computational approaches to pharmaceutical manufacturing challenges, particularly in the areas of powder flow prediction and tablet dissolution performance modeling. Armstrong's research interests span pharmaceutical powder flow prediction, deep learning applications in pharmaceuticals, tablet dissolution performance modeling, pharmaceutical crystallization, and computational modeling for pharmaceutical manufacturing. His work integrates advanced computational techniques with pharmaceutical science to improve manufacturing processes and product quality. His recent publications demonstrate a strong focus on applying machine learning and computational modeling to solve practical pharmaceutical manufacturing challenges. The 2024 paper on flexible modeling of tablet dissolution shows how computational approaches can predict drug release profiles, while the 2023 deep learning study demonstrates innovative methods for predicting powder flow from microscopy images, bridging the gap between material characterization and process performance. Armstrong serves as Principal Investigator for the project "From Pixels to Particles: A Computational Toolbox for Predicting Pharmaceutical Powder Characteristics" (2023-2024), which develops computational tools to predict pharmaceutical powder properties from image data. His research is closely aligned with the CMAC (Continuous Manufacturing and Crystallisation) facility at Strathclyde, contributing to advancements in continuous pharmaceutical manufacturing.

Taravat Ghafourianمشاهده پروفایل

دانشیار

• Drug Discovery
• Drug Delivery
• Pharmacological Properties Prediction
• +۷ مورد دیگر

Taravat Ghafourian is an Associate Professor at the Department of Pharmaceutical Sciences within the Barry and Judy Silverman College of Pharmacy at Nova Southeastern University. She joined NSU in 2022 after holding academic positions at UK institutions like the University of Kent and the University of Sussex for over two decades. Ph.D. in Pharmaceutical Chemistry, Liverpool John Moores University Pharm.D. , Tabriz University of Medical Sciences Postgraduate Certificate in Higher Education, University of Kent Postdoctoral Research , University College London (UCL) and Liverpool John Moores University Her research focuses on integrating cheminformatics and machine learning with in vitro experiments to predict pharmacological and toxicological properties of drugs. Key areas include: Mitochondrial Bioenergetics : Modeling mitochondrial function and drug-induced dysfunction. ADME/Tox Prediction : Drug distribution, elimination routes, and pharmacokinetics. Drug Discovery : Virtual screening, rational drug design, and repurposing. Pharmaceutical Excipients : Impact on transdermal and oral delivery endpoints. Mental Health Drug Effects : Side effect prediction and biomarker detection for Alzheimer’s disease. Transporter Protein Interactions : ABC and SLC transporter studies. The 15 most recent articles highlight trends in: Mitochondrial Modeling : Bioenergetics, Complex IV dynamics, and oxidative stress. Drug Delivery Innovation : Nanocomposites, inhalation formulations, and 3D printing. Machine Learning Applications : Biomarker detection, toxicity prediction, and QSAR. Excipient Effects : Stability, solubility, and polymer interactions. Pharmaceutical Toxicology : Hepatotoxicity, phospholipidosis, and inflammasome activation. Scientific Awards : Fellow of the UK Higher Education Academy (FHEA) Dr. Ghafourian has supervised numerous Ph.D. and Pharm.D. students and led research projects on drug safety and delivery. She serves as Associate Editor of Molecular Diversity and editorial board member of multiple journals.

• Pharmaceutical 3D Printing
• Hydrocortisone Therapy
• Adrenal Insufficiency Treatment
• +۲ مورد دیگر

Sejad Ayyoubi is a researcher in the Department of Pharmacy at Erasmus University Medical Center, actively contributing to pharmaceutical sciences with a focus on innovative drug delivery systems. His work bridges clinical pharmacology and advanced manufacturing techniques. His research interests center on pharmaceutical 3D printing applications , particularly for hydrocortisone therapy in adrenal insufficiency and child-friendly medicine formulation . Key areas include sustained-release drug delivery, excipient optimization, and cost analysis of personalized pharmaceutical manufacturing, with significant contributions to pediatric pharmacotherapy. Analysis of his publications reveals a strong trend in translational research converting 3D printing technology into clinical applications for endocrine disorders. His work demonstrates expertise in both material science (lactose/excipient formulation) and clinical implementation (personalized dosing for adrenal patients), with growing impact evidenced by Scopus citations. No scientific awards are documented in the provided materials. Regarding academic supervision and funding, no student advisees or specific grant information appears in the current profile. His collaborative network shows international partnerships, particularly with researchers in Belgium (Evrard, Lechanteur) and the Netherlands (Ruijgrok, van Kampen). While no dedicated laboratory is explicitly mentioned, his research operates within Erasmus MC's pharmaceutical technology infrastructure, focusing on 3D semi-solid extrusion printing for medicine production, with evident connections to clinical endocrinology departments through adrenal insufficiency studies.

• Pharmaceutical Sciences
• Drug Delivery Systems
• 3D Printing in Medicine
• +۴ مورد دیگر

Eveline van Kampen is a researcher in the Department of Pharmacy at Erasmus MC, specializing in pharmaceutical sciences and 3D printing applications in drug delivery. Her work focuses on personalized dosage forms, excipient development, and treatment innovations for adrenal insufficiency. Research Trends: Recent publications highlight her expertise in 3D printed sustained-release medications, child-friendly pharmaceutical formulations, and excipient optimization. Key subfields include hydrocortisone administration, semi-solid extrusion techniques, and clinical pharmacotherapy. Publications: Her research output (2022-2025) spans journals like Pharmaceutics , International Journal of Pharmaceutics , and Archives of Disease in Childhood , emphasizing interdisciplinary collaboration in drug manufacturing and patient-centered pharmacotherapy.